Mega Genomics (HKSE:06667) Days Sales Outstanding : 504.40 (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Mega Genomics Days Sales Outstanding?

Mega Genomics's average Accounts Receivable for the six months ended in Dec. 2023 was HK$158.5 Mil. Mega Genomics's Revenue for the six months ended in Dec. 2023 was HK$57.3 Mil. Hence, Mega Genomics's Days Sales Outstanding for the six months ended in Dec. 2023 was 504.40.

The historical rank and industry rank for Mega Genomics's Days Sales Outstanding or its related term are showing as below:

HKSE:06667' s Days Sales Outstanding Range Over the Past 10 Years
Min: 208.1 Med: 319.04 Max: 511.08
Current: 384.75

During the past 5 years, Mega Genomics's highest Days Sales Outstanding was 511.08. The lowest was 208.10. And the median was 319.04.

HKSE:06667's Days Sales Outstanding is ranked worse than
93.58% of 218 companies
in the Medical Diagnostics & Research industry
Industry Median: 69.88 vs HKSE:06667: 384.75

Mega Genomics's Days Sales Outstanding declined from Dec. 2022 (861.41) to Dec. 2023 (504.40).

Mega Genomics Days Sales Outstanding Historical Data

The historical data trend for Mega Genomics's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mega Genomics Days Sales Outstanding Chart

Mega Genomics Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

319.04

208.10

253.69

511.08

367.38

Mega Genomics Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial			264.78	438.69	861.41	334.61	504.40

Competitive Comparison of Mega Genomics's Days Sales Outstanding

For the Diagnostics & Research subindustry, Mega Genomics's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mega Genomics's Days Sales Outstanding Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Mega Genomics's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Mega Genomics's Days Sales Outstanding falls into.

Mega Genomics Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Mega Genomics's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (206.395	+	126.744)	/	2 )	/	165.489	*	365
=	166.5695					/	165.489	*	365
=	367.38

Mega Genomics's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (190.194	+	126.744)	/	2 )	/	57.337	*	365 / 2
=	158.469					/	57.337	*	365 / 2
=	504.40

Mega Genomics (HKSE:06667) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Mega Genomics Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Mega Genomics's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Mega Genomics (HKSE:06667) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Mega Genomics Ltd (HKSE:06667) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

North Garden Road, 401 Health Work, Haidian District, Beijing, CHN

Website

https://www.megagenomics.cn

Mega Genomics Ltd is a genetic testing platform company in China with a focus on consumer genetic testing and cancer screening services. The company has launched dozens of testing services, covering a wide range of fields such as nutrition and metabolism, cancer risk assessment, chronic disease susceptibility, cancer screening and infectious disease diagnosis, to meet consumers' growing preventive medical needs.

Executives

Guo Meiling	2101 Beneficial owner
Lin Lin	2101 Beneficial owner
Yu Rong	2501 Other
Infinite Galaxy Health Limited	2101 Beneficial owner
Mei Nian Investment Limited	2101 Beneficial owner
Kastle Limited	2501 Other
Mega Marvelous Limited	2501 Other
Yurong Technology Limited	2101 Beneficial owner
Niu Zhencai	2201 Interest of corporation controlled by you
Mei Nian Da Jian Kang Chan Ye Kong Gu Gu Fen You Xian Gong Si	2201 Interest of corporation controlled by you
Bei Jing He He Heng Ye Ke Ji You Xian Gong Si	2201 Interest of corporation controlled by you
Bei Jing Shi Ji Yu Neng Ke Ji You Xian Gong Si	2501 Other
Tian Jin Shi Ji Yu Neng Qi Ye Guan Li He Huo Qi Ye You Xian He Huo	2101 Beneficial owner

Mega Genomics (HKSE:06667) Headlines

No Headlines